Phyllis Olszewski v. HHS - Influenza, Guillain-Barré syndrome (2023)

Phyllis Olszewski filed a petition for compensation under the National Vaccine Injury Compensation Program on June 29, 2022. She alleged that she developed Guillain-Barré syndrome (GBS) as a result of an influenza vaccine administered on October 14, 2019.

The respondent conceded that Ms. Olszewski was entitled to compensation, agreeing that her condition met the criteria set forth in the Vaccine Injury Table and its Qualifications and Aids to Interpretation.

A ruling on entitlement was issued on May 3, 2023, finding her eligible for compensation. Subsequently, on October 24, 2023, the respondent filed a proffer on award of compensation.

The parties agreed to an award of $183,958.00, which included $182,500.00 for pain and suffering and $1,458.00 for past unreimbursable expenses. This amount was intended to compensate for all damages available under the Vaccine Act.

The decision awarding damages was issued on November 28, 2023, granting the lump sum payment to Ms. Olszewski, who is a competent adult.